Trial NCT04398368

View at ClinicalTrials.gov 
Org. Study IDs: 19-009444
Secondary IDs: 19-009444 NCI-2020-03336

Last trial update was posted on 2023-08-08

MeSH Interventions

Gemcitabine

MeSH Conditions

Kidney Neoplasms Pelvic Neoplasms Ureteral Neoplasms

Other Conditions

Stage 0a Renal Pelvis Cancer AJCC v8 Stage 0a Renal Pelvis and Ureter Cancer AJCC v8 Stage 0a Ureter Cancer AJCC v8 Stage 0is Renal Pelvis Cancer AJCC v8 Stage 0is Renal Pelvis and Ureter Cancer AJCC v8 Stage 0is Ureter Cancer AJCC v8 Stage I Renal Pelvis Cancer AJCC v8 Stage I Renal Pelvis and Ureter Cancer AJCC v8 Stage I Ureter Cancer AJCC v8 Stage II Renal Pelvis Cancer AJCC v8 Stage II Renal Pelvis and Ureter Cancer AJCC v8 Stage II Ureter Cancer AJCC v8 Stage III Renal Pelvis Cancer AJCC v8 Stage III Renal Pelvis and Ureter Cancer AJCC v8 Stage III Ureter Cancer AJCC v8 Stage IV Renal Pelvis Cancer AJCC v8 Stage IV Renal Pelvis and Ureter Cancer AJCC v8 Stage IV Ureter Cancer AJCC v8

Stopping Reasons

Focus research efforts on other projects.

Limitations And Caveats

Study target enrollment was anticipated for 90 participants but only 23 participants completed treatment before study was terminated. The study was terminated due to insufficient resources and funding to support continuation of the trial. PI decision to terminate.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID